These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7958988)

  • 1. In vitro inhibition of the pim-1 protooncogene by chimeric oligodeoxyribonucleotides composed of alpha- and beta-anomeric fragments.
    Gottikh M; Baud-Demattei MV; Lescot E; Giorgi-Renault S; Shabarova Z; Dautry F; Malvy C; Bertrand JR
    Gene; 1994 Nov; 149(1):5-12. PubMed ID: 7958988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha beta chimeric antisense oligonucleotides: synthesis and nuclease resistance in biological media.
    Gottikh M; Bertrand JR; Baud-Dematteï MV; Lescot E; Giorgi-Renault S; Shabarova Z; Malvy C
    Antisense Res Dev; 1994; 4(4):251-8. PubMed ID: 7734939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of anti-RNA properties of normal and ellipticine functionalized alpha and beta-oligonucleotides.
    Lavignon M; Bertrand JR; Porumb H; Rayner B; Imbach JL; Paoletti C; Malvy C
    Nucleic Acids Symp Ser; 1991; (24):117-9. PubMed ID: 1668683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNase H-mediated inhibition of translation by antisense oligodeoxyribonucleotides: use of backbone modification to improve specificity.
    Larrouy B; Blonski C; Boiziau C; Stuer M; Moreau S; Shire D; Toulmé JJ
    Gene; 1992 Nov; 121(2):189-94. PubMed ID: 1332911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second-generation antisense oligonucleotides: structure-activity relationships and the design of improved signal-transduction inhibitors.
    Altmann KH; Fabbro D; Dean NM; Geiger T; Monia BP; Müller M; Nicklin P
    Biochem Soc Trans; 1996 Aug; 24(3):630-7. PubMed ID: 8878817
    [No Abstract]   [Full Text] [Related]  

  • 6. 9-Aminoellipticine-derivatized alpha- and beta-oligodeoxyribonucleotides targeted to the cap of beta-globin mRNA: hybridization to natural and engineered mRNA, inhibition of translation, and improved effect of tandem chains.
    Porumb H; Bertrand JR; Paoletti J; Vasseur JJ; Rayner B; Imbach JL; Malvy C
    Antisense Res Dev; 1992; 2(4):279-92. PubMed ID: 1292777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translation inhibition by phosphorothioate oligodeoxynucleotides in cell-free systems.
    Ghosh MK; Ghosh K; Cohen JS
    Antisense Res Dev; 1992; 2(2):111-8. PubMed ID: 1327332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligodeoxynucleotide analogs as informational drugs to regulate translation.
    Ghosh M; Ghosh K; Cohen JS
    Nucleic Acids Symp Ser; 1991; (24):139-42. PubMed ID: 1668685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the proto-oncogene pim-1: kinase activity and substrate recognition sequence.
    Friedmann M; Nissen MS; Hoover DS; Reeves R; Magnuson NS
    Arch Biochem Biophys; 1992 Nov; 298(2):594-601. PubMed ID: 1416988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of RNase H in hybrid-arrested translation by antisense oligonucleotides.
    Walder RY; Walder JA
    Proc Natl Acad Sci U S A; 1988 Jul; 85(14):5011-5. PubMed ID: 2839827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of translation initiation by antisense oligonucleotides via an RNase-H independent mechanism.
    Boiziau C; Kurfurst R; Cazenave C; Roig V; Thuong NT; Toulmé JJ
    Nucleic Acids Res; 1991 Mar; 19(5):1113-9. PubMed ID: 1850511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mechanism for suppression mRNA translation with antisense oligonucleotides].
    Vlasov VV; Iurchenko LV
    Mol Biol (Mosk); 1990; 24(5):1157-61. PubMed ID: 2290415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorothioate oligonucleotides are inhibitors of human DNA polymerases and RNase H: implications for antisense technology.
    Gao WY; Han FS; Storm C; Egan W; Cheng YC
    Mol Pharmacol; 1992 Feb; 41(2):223-9. PubMed ID: 1371582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carba-LNA-5MeC/A/G/T modified oligos show nucleobase-specific modulation of 3'-exonuclease activity, thermodynamic stability, RNA selectivity, and RNase H elicitation: synthesis and biochemistry.
    Upadhayaya R; Deshpande SG; Li Q; Kardile RA; Sayyed AY; Kshirsagar EK; Salunke RV; Dixit SS; Zhou C; Földesi A; Chattopadhyaya J
    J Org Chem; 2011 Jun; 76(11):4408-31. PubMed ID: 21500818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A more efficient and specific strategy in the ablation of mRNA in Xenopus laevis using mixtures of antisense oligos.
    Morgan R; Edge M; Colman A
    Nucleic Acids Res; 1993 Sep; 21(19):4615-20. PubMed ID: 8233799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative activity of alpha- and beta-anomeric oligonucleotides on rabbit beta globin synthesis: inhibitory effect of cap targeted alpha-oligonucleotides.
    Bertrand JR; Rayner B; Imbach JL; Paoletti C; Malvy C
    Biochem Biophys Res Commun; 1989 Oct; 164(1):311-8. PubMed ID: 2803305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the terminal phosphate derivatization of beta- and alpha-oligodeoxynucleotides on their antisense activity in protein biosynthesis, stability and uptake by eucaryotic cells.
    Boutorine AS; Boiziau C; Le Doan T; Toulmé JJ; Hélène C
    Biochimie; 1992 May; 74(5):485-9. PubMed ID: 1322180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNase H is responsible for the non-specific inhibition of in vitro translation by 2'-O-alkyl chimeric oligonucleotides: high affinity or selectivity, a dilemma to design antisense oligomers.
    Larrouy B; Boiziau C; Sproat B; Toulmé JJ
    Nucleic Acids Res; 1995 Sep; 23(17):3434-40. PubMed ID: 7567453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modified oligonucleotides in rabbit reticulocytes: uptake, stability and antisense properties.
    Boiziau C; Toulmé JJ
    Biochimie; 1991 Nov; 73(11):1403-8. PubMed ID: 1799634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability changes in pim-1 proto-oncogene mRNA after mitogen stimulation of normal lymphocytes.
    Wingett D; Reeves R; Magnuson NS
    J Immunol; 1991 Nov; 147(10):3653-9. PubMed ID: 1940364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.